You have 9 free searches left this month | for more free features.

A2b

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Burns Surgery Trial in Paris (active intervention, intervention)

Recruiting
  • Burns Surgery
  • active intervention
  • placebo intervention
  • Paris, France
    Saint Louis Hospital
Aug 8, 2022

Solid Tumor, Adult, Colorectal Cancer, NSCLC Trial in United States (A2B694, xT CDx with HLA-LOH Assay)

Not yet recruiting
  • Solid Tumor, Adult
  • +19 more
  • A2B694
  • xT CDx with HLA-LOH Assay
  • Duarte, California
  • +9 more
Sep 22, 2023

Solid Tumor, Adult, Solid Tumor, Pancreatic Cancer Trial in United States (A2B530, xT-Onco with HLA-LOH Assay)

Not yet recruiting
  • Solid Tumor, Adult
  • +15 more
  • A2B530
  • xT-Onco with HLA-LOH Assay
  • Duarte, California
  • +6 more
Feb 10, 2023

MDS Trial (AG-946, Placebo)

Not yet recruiting
  • Myelodysplastic Syndromes
  • (no location specified)
Aug 4, 2022

Nonalcoholic Steatohepatitis (NASH) Trial (ASC41 2 mg, ASC41 4 mg, Placebo)

Not yet recruiting
  • Nonalcoholic Steatohepatitis (NASH)
  • ASC41 2 mg
  • +2 more
  • (no location specified)
Jan 30, 2023

Chronic Hepatitis B Trial run by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (VIR-2218 and

Not yet recruiting
  • Chronic Hepatitis B
  • VIR-2218 and peginterferon alfa-2a
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Oct 27, 2023

Natural History Study for Charcot Marie Tooth Disease

Recruiting
  • Charcot-Marie-Tooth Disease
  • +47 more
    • New York, New York
      Hereditary Neuropathy Foundation
    Jun 12, 2023

    Influenza A, Influenza Type B, SARS CoV 2 Infection Trial in Raleigh (Diagnostic Test for identification of influenzas A,

    Not yet recruiting
    • Influenza A
    • +3 more
    • Diagnostic Test for identification of influenzas A, influenzas B, RSV and SARS-CoV-2 infections
    • Raleigh, North Carolina
      Wake Med
    Jun 26, 2023

    Amyotrophic Lateral Sclerosis Trial in Fredericton, Montréal (Reldesemtiv)

    Recruiting
    • Amyotrophic Lateral Sclerosis
    • Fredericton, New Brunswick, Canada
    • +1 more
    Aug 9, 2022

    Advanced Solid Tumor Trial (Utidelone Capsule (Part 1), Drug A Utidelone Capsule (Part 2: Group A-B), Drug A Utidelone Capsule

    Not yet recruiting
    • Advanced Solid Tumor
    • Utidelone Capsule (Part 1)
    • +4 more
    • (no location specified)
    Jan 16, 2023

    Locally Advanced or Recurrent Metastatic HER-2 Negative Breast Cancer Trial in Shanghai (BL-B01D1, SI-B003)

    Not yet recruiting
    • Locally Advanced or Recurrent Metastatic HER-2 Negative Breast Cancer
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Sep 12, 2023

    Clinical Validation of the LumiraDx SARS-CoV-2 & Flu A/B Test

    Not yet recruiting
    • SARS-CoV-2
    • +3 more
    • LumiraDx SARS-CoV-2 & Flu A/B
    • Cullman, Alabama
      Cullman Clinical Trials
    Mar 16, 2023

    Novel Functional Eye-Tracking Software Application for Multiple

    Recruiting
    • Multiple Sclerosis
    • Eye-Tracking
    • Montreal, Quebec, Canada
    • +1 more
    Dec 14, 2022

    Hepatitis B, Chronic Trial in Hefei (PEGylated recombinant human interferon alpha-2b injection)

    Recruiting
    • Hepatitis B, Chronic
    • PEGylated recombinant human interferon alpha-2b injection
    • Hefei, Anhui, China
      The First Affiliated Hospital of Anhui Medical University
    Jun 24, 2023

    Polycythemia Vera Trial in Tianjin (Ruxolitinib, Pegylated interferon a-2b)

    Recruiting
    • Polycythemia Vera
    • Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    May 19, 2023

    Cancer, Relapsed/Refractory Large B-cell Lymphoma (LBCL) Trial (Fludarabine (30 mg/m^2), Cyclophosphamide (500 mg/m^2), CRG-022

    Not yet recruiting
    • Cancer
    • Relapsed/Refractory Large B-cell Lymphoma (LBCL)
    • Fludarabine (30 mg/m^2)
    • +2 more
    • (no location specified)
    Jul 25, 2023

    LumiraDX SARS-CoV-2 Ag Ultra and LumiraDX SARS-CoV-2 & Flu A/B

    Not yet recruiting
    • SARS-CoV-2
    • +4 more
    • LumiraDx SARS-CoV-2 Ag Ultra
    • LumiraDx SARS-CoV-2 & Flu A/B
    • DeLand, Florida
      Hillcrest Medical Research
    Feb 6, 2023

    Healthy Aging Trial in Montréal (Computerized Plasticity-Based Adaptive Cognitive Training, Commercially available computerized

    Recruiting
    • Healthy Aging
    • Computerized Plasticity-Based Adaptive Cognitive Training
    • Commercially available computerized training
    • Montréal, Quebec, Canada
      McGill University
    Sep 8, 2022

    Implementation ofNovel Functional Eye-Tracking Biomarker for

    Recruiting
    • Clinically Isolated Syndrome
    • Relapsing Remitting Multiple Sclerosis
    • Eye-tracking
    • Montréal, Quebec, Canada
      Montreal Neurological Institute and Hospital
    Sep 2, 2022

    Amyotrophic Lateral Sclerosis Trial in Montreal (Enoxacin, Placebo)

    Recruiting
    • Amyotrophic Lateral Sclerosis
    • Montreal, Quebec, Canada
      Montreal Neurological Institute-Hospital
    Aug 10, 2022

    Limb Girdle Muscular Dystrophy Trial in Columbus (SRP-6004)

    Enrolling by invitation
    • Limb Girdle Muscular Dystrophy
    • SRP-6004
    • Columbus, Ohio
      Nationwide Children's Hospital
    Jun 7, 2023

    Functional Cure of Hepatitis B in HIV/HBV Co-infected Patients

    Recruiting
    • AIDS
    • Hepatitis B
    • Peginterferon alfa-2b Injection
    • Guangzhou, Guangdong, China
      Guangzhou Eighth People's Hospital, Guangzhou Medical University
    Aug 10, 2023

    Intradialytic Hypotension Trial (Icatibant, Placebo)

    Not yet recruiting
    • Intradialytic Hypotension
    • (no location specified)
    Apr 17, 2023

    Subcutaneous Fat Trial in Omaha (CBL-514 injection, CBL-A1 Injection, CBL-A2 Injection)

    Not yet recruiting
    • Subcutaneous Fat
    • CBL-514 injection
    • +3 more
    • Omaha, Nebraska
      Investigational Site 1
    Aug 17, 2023

    Understand is COVID-19 Vaccine BNT162b2 is Safe in Indonesia

    Not yet recruiting
    • COVID-19
    • BNT162b2
    • (no location specified)
    Nov 16, 2022